PageSourceSearch

https://synage.ee/assets/KetoPage-ClV9j5qx.js

js synage.ee collected 2026-10-09 17:14:58 UTC 56,201 bytes, 14 lines download raw bytes

1import{aa as z,j as e,E as B,d as k,e as R,aB as V,af as E,r as A,L as I,w as $,A as _,H as O,S as L,f as y,o as M,T as G,M as U,h as W,al as J}from"./index-DY9IdTRN.js";import{C as Q}from"./compass-CkRFoati.js";import{E as X,B as g,a as Y}from"./brand-pdf-CQp-m5SS.js";import{U as Z}from"./utensils-CSyxLyzz.js";import{D as ee}from"./download-Dfwr4GMw.js";import{R as ae}from"./ResponsiveTable-hJrblYMa.js";import{N as te,C as ie}from"./ContentSafety-US9T3zT6.js";import{S as se}from"./scale-Nez-N4Ma.js";import{A as re}from"./arrow-up-right-CEKECuWE.js";const oe=[["path",{d:"M15 12h-5",key:"r7krc0"}],["path",{d:"M15 8h-5",key:"1khuty"}],["path",{d:"M19 17V5a2 2 0 0 0-2-2H4",key:"zz82l3"}],["path",{d:"M8 21h12a2 2 0 0 0 2-2v-1a1 1 0 0 0-1-1H11a1 1 0 0 0-1 1v1a2 2 0 1 1-4 0V5a2 2 0 1 0-4 0v2a1 1 0 0 0 1 1h3",key:"1ph1d7"}]],ne=z("scroll-text",oe),D={et:{note:"Kui see teenus päris ei sobi, vaata alternatiive – või broneeri lühike esmavisiit ja otsustame koos.",all:"Vaata kõiki teenuseid",quiz:"Ei tea, mis sobib? Tee 1-minutiline test",fallback:"Broneeri 25-minutiline esmavisiit",fallbackNote:"Lühike vestlus arstiga, et valida sulle sobiv suund."},ru:{note:"Если эта услуга не совсем подходит, посмотрите альтернативы – или запишитесь на короткий первичный визит, и мы решим вместе.",all:"Все услуги",quiz:"Не знаете, что подходит? Пройдите тест за 1 минуту",fallback:"Записаться на первичный визит 25 мин",fallbackNote:"Короткая беседа с врачом, чтобы выбрать подходящее направление."},en:{note:"If this service is not quite right, see the alternatives – or book a short first visit and we will decide together.",all:"See all services",quiz:"Not sure what fits? Take the 1-minute quiz",fallback:"Book a 25-minute first visit",fallbackNote:"A short conversation with the doctor to choose the right direction."}};function T(t,i){return t==="et"?i:`/${t}${i}`}function le({ids:t,locale:i="et",note:s}){const o=D[i]??D.et;return e.jsxs(e.Fragment,{children:[e.jsx(B,{ids:t,locale:i,note:s??o.note}),e.jsx("section",{className:"border-t border-border bg-card/40",children:e.jsx("div",{className:"mx-auto max-w-6xl px-4 sm:px-6 lg:px-8 py-10 lg:py-12",children:e.jsxs("div",{className:"flex flex-col gap-6 lg:flex-row lg:items-center lg:justify-between",children:[e.jsxs("div",{className:"flex flex-wrap items-center gap-x-6 gap-y-3",children:[e.jsxs(k,{to:T(i,"/konsultatsioonid"),"data-track-event":"cross_sell_click","data-track-param-target":"all_services",className:"inline-flex items-center gap-2 text-sm font-medium text-foreground underline decoration-border underline-offset-4 hover:text-primary hover:decoration-primary/50 transition",children:[o.all," ",e.jsx(R,{className:"h-4 w-4"})]}),e.jsxs(k,{to:T(i,"/programmi-sobivus"),"data-track-event":"cross_sell_click","data-track-param-target":"quiz",className:"inline-flex items-center gap-2 text-sm font-medium text-foreground/75 underline decoration-border underline-offset-4 hover:text-primary hover:decoration-primary/50 transition",children:[e.jsx(Q,{className:"h-4 w-4"})," ",o.quiz]})]}),e.jsxs("div",{className:"rounded-3xl border border-border bg-card p-5 sm:p-6 shadow-[var(--shadow-soft)]",children:[e.jsx("p",{className:"text-sm leading-relaxed text-muted-foreground",children:o.fallbackNote}),e.jsxs(k,{to:"/broneeri/$serviceId",params:{serviceId:"kons-25"},search:i==="et"?void 0:{lang:i},"data-track-event":"click_booking","data-track-param-service_id":"kons-25","data-track-param-position":"service_page_footer",className:"mt-4 inline-flex items-center justify-center gap-2 rounded-full bg-primary px-5 py-3 text-sm font-medium text-primary-foreground transition hover:opacity-90",children:[e.jsx(V,{className:"h-4 w-4"})," ",o.fallback]})]})]})})})]})}const de="/assets/breakfast-D_UfSOP7.jpg",ce="/assets/lunch-wtW75Imb.jpg",me="/assets/snack-DInlSH9j.jpg",ue="/assets/dinner-SQR3_AiN.jpg",h=[{key:"breakfast",img:de,time:{et:"08:00 · Hommikusöök",ru:"08:00 · Завтрак",en:"08:00 · Breakfast"},title:{et:"Munad avokaados ja suitsulõhe",ru:"Яйца в авокадо и копчёный лосось",en:"Baked eggs in avocado with smoked salmon"},items:{et:`½ avokaadot · 2 muna · 40 g suitsulõhet
2peotäis spinatit · oliiviõli · meresool`,ru:`½ авокадо · 2 яйца · 40 г копчёного лосося
3горсть шпината · оливковое масло · морская соль`,en:`½ avocado · 2 eggs · 40 g smoked 
3salmon
4handful of spinach · olive oil · sea salt`},kcal:480,fat:38,protein:26,carbs:6},{key:"lunch",img:ce,time:{et:"13:00 · Lõunasöök",ru:"13:00 · Обед",en:"13:00 · Lunch"},title:{et:"Grillitud lõhe rukolasalatiga",ru:"Лосось на гриле с салатом из рукколы",en:"Grilled salmon with arugula salad"},items:{et:`150 g lõhet · sidrun · rosmariin
5spargel · rukola · oliiviõli · parmesan`,ru:`150 г лосося · лимон · розмарин
6спаржа · руккола · оливковое масло · пармезан`,en:`150 g salmon · lemon · rosemary
7asparagus · arugula · olive oil · parmesan`},kcal:560,fat:40,protein:38,carbs:8},{key:"snack",img:me,time:{et:"16:30 · Vahepala",ru:"16:30 · Перекус",en:"16:30 · Snack"},title:{et:"Pähklid, juust ja oliivid",ru:"Орехи, сыр и оливки",en:"Nuts, cheese and olives"},items:{et:`20 g mandleid · 15 g kreeka pähkleid
830 g laagerdunud juustu · 5 rohelist oliivi`,ru:`20 г миндаля · 15 г грецких орехов
930 г выдержанного сыра · 5 зелёных оливок`,en:`20 g almonds · 15 g walnuts
1030 g aged cheese · 5 green olives`},kcal:310,fat:28,protein:10,carbs:5},{key:"dinner",img:ue,time:{et:"19:00 · Õhtusöök",ru:"19:00 · Ужин",en:"19:00 · Dinner"},title:{et:"Ribeye steik röstitud köögiviljadega",ru:"Стейк рибай с запечёнными овощами",en:"Ribeye steak with roasted vegetables"},items:{et:`180 g ribeye steiki · rosmariinivõi
11brokkoli · lillkapsas · ürdivõi · meresool`,ru:`180 г стейка рибай · сливочное масло с розмарином
12брокколи · цветная капуста · сливочное масло с травами · морская соль`,en:`180 g ribeye · rosemary butter
13broccoli · cauliflower · herb butter · sea salt`},kcal:680,fat:52,protein:46,carbs:9}],pe={et:{eyebrow:"Näidismenüü",title:"Ketogeenne menüü – üks päev",lead:"Näidispäev umbes 2000 kcal juures: kõrge rasva-, mõõduka valgu- ja madala süsivesikusisaldusega. Kogused ja proportsioonid sõltuvad kaalust, aktiivsusest ja terviseseisundist – kohanda koos oma arstiga.",note:"See on hariduslik näide, mitte individuaalne raviplaan. Kui kasutad ravimeid, konsulteeri enne toitumismuudatust arstiga.",totals:"Päeva kokku",kcal:"kcal",fat:"rasv",protein:"valk",carbs:"süsivesikud",download:"Laadi PDF-ina alla",downloading:"Valmistan PDF-i…",pdfTitle:"Ketogeenne menüü – üks päev",pdfSubtitle:"Näidismenüü hariduslikul eesmärgil · Synage Health",pdfNote:"Hariduslik näide, mitte individuaalne raviplaan. Kui kasutad ravimeid, konsulteeri arstiga."},ru:{eyebrow:"Пример меню",title:"Кетогенное меню – один день",lead:"Ориентировочный день на ~2000 ккал: с высоким содержанием жиров, умеренным – белков и низким – углеводов. Порции и пропорции подбираются под вес, активность и состояние здоровья – согласуйте с врачом.",note:"Это образовательный пример, а не индивидуальный план лечения. При приёме лекарств обсудите изменения питания с врачом.",totals:"Итого за день",kcal:"ккал",fat:"жиры",protein:"белки",carbs:"углеводы",download:"Скачать в PDF",downloading:"Готовлю PDF…",pdfTitle:"Кетогенное меню – один день",pdfSubtitle:"Пример меню в образовательных целях · Synage Health",pdfNote:"Образовательный пример, а не индивидуальный план лечения. При приёме лекарств проконсультируйтесь с врачом."},en:{eyebrow:"Sample menu",title:"Ketogenic menu – one day",lead:"A sample day of about 2000 kcal: high in fat, moderate in protein and low in carbohydrate. Portions and ratios depend on weight, activity and health – adjust in consultation with your doctor.",note:"This is an educational example, not an individual treatment plan. If you take medications, consult your doctor before making dietary changes.",totals:"Daily total",kcal:"kcal",fat:"fat",protein:"protein",carbs:"carbs",download:"Download as PDF",downloading:"Building PDF…",pdfTitle:"Ketogenic menu – one day",pdfSubtitle:"Educational sample menu · Synage Health",pdfNote:"Educational example, not an individual treatment plan. If you take medications, consult your doctor before making dietary changes."}};async function ge(t){const s=await(await fetch(t)).blob();return await new Promise((o,l)=>{const c=new FileReader;c.onload=()=>o(c.result),c.onerror=l,c.readAsDataURL(s)})}function he(){const{locale:t}=E(),i=pe[t],[s,o]=A.useState(!1),l=h.reduce((a,d)=>({kcal:a.kcal+d.kcal,fat:a.fat+d.fat,protein:a.protein+d.protein,carbs:a.carbs+d.carbs}),{kcal:0,fat:0,protein:0,carbs:0}),c=async()=>
13{if(!s){o(!0);try{const a=new X({unit:"mm",format:"a4"}),d=a.internal.pageSize.getWidth(),[b,f,v]=g.teal;a.setFont("helvetica","bold"),a.setFontSize(22),a.setTextColor(...g.ink),a.text(i.pdfTitle,14,32),a.setFont("helvetica","normal"),a.setFontSize(10),a.setTextColor(...g.muted),a.text(i.pdfSubtitle,14,39),a.setFontSize(10.5),a.setTextColor(60,60,60);const N=a.splitTextToSize(i.lead,d-28);a.text(N,14,48);let n=48+N.length*5+4;const K=await Promise.all(h.map(u=>ge(u.img)));for(let u=0;u<h.length;u++){const m=h[u],x=44;n+x>260&&(a.addPage(),n=30);try{a.addImage(K[u],"JPEG",14,n,56,x,void 0,"FAST")}catch{}const p=76;a.setFont("helvetica","bold"),a.setFontSize(9),a.setTextColor(b,f,v),a.text(m.time[t].toUpperCase(),p,n+6),a.setFont("helvetica","bold"),a.setFontSize(13),a.setTextColor(...g.ink);const S=a.splitTextToSize(m.title[t],d-p-14);a.text(S,p,n+13),a.setFont("helvetica","normal"),a.setFontSize(10),a.setTextColor(70,70,70);const P=m.items[t].split(`
14`).flatMap(q=>a.splitTextToSize(q,d-p-14));a.text(P,p,n+13+S.length*5+3),a.setFont("helvetica","bold"),a.setFontSize(9),a.setTextColor(b,f,v);const F=`${m.kcal} ${i.kcal}  ·  ${i.fat} ${m.fat} g  ·  ${i.protein} ${m.protein} g  ·  ${i.carbs} ${m.carbs} g`;a.text(F,p,n+x-2),n+=x+6}n+24>270&&(a.addPage(),n=30),a.setDrawColor(220,220,220),a.setLineWidth(.3),a.line(14,n,d-14,n),n+=8,a.setFont("helvetica","bold"),a.setFontSize(11),a.setTextColor(...g.ink),a.text(i.totals,14,n),a.setFont("helvetica","normal"),a.setFontSize(10),a.setTextColor(b,f,v),a.text(`${l.kcal} ${i.kcal}  ·  ${i.fat} ${l.fat} g  ·  ${i.protein} ${l.protein} g  ·  ${i.carbs} ${l.carbs} g`,d-14,n,{align:"right"}),n+=10,a.setFont("helvetica","italic"),a.setFontSize(9),a.setTextColor(...g.muted);const H=a.splitTextToSize(i.pdfNote,d-28);a.text(H,14,n),Y(a,t),a.save(`synage-keto-menu-${t}.pdf`)}finally{o(!1)}}};return e.jsxs("section",{className:"mx-auto max-w-6xl px-4 sm:px-6 lg:px-8 py-16 lg:py-20",children:[e.jsxs("div",{className:"max-w-3xl",children:[e.jsxs("div",{className:"inline-flex items-center gap-2 text-[13px] uppercase tracking-[0.22em] text-primary",children:[e.jsx(Z,{className:"h-3.5 w-3.5"})," ",i.eyebrow]}),e.jsx("h2",{className:"mt-3 font-serif text-3xl sm:text-4xl text-foreground leading-tight",children:i.title}),e.jsx("p",{className:"mt-4 text-base sm:text-lg leading-relaxed text-muted-foreground",children:i.lead})]}),e.jsx("div",{className:"mt-10 grid gap-6 sm:grid-cols-2",children:h.map(a=>e.jsxs("article",{className:"group overflow-hidden rounded-2xl border border-border bg-card shadow-[var(--shadow-soft)] transition hover:shadow-lg",children:[e.jsx("div",{className:"aspect-[4/3] overflow-hidden bg-muted",children:e.jsx("img",{src:a.img,alt:a.title[t],width:1024,height:768,loading:"lazy",className:"h-full w-full object-cover transition duration-500 group-hover:scale-[1.03]"})}),e.jsxs("div",{className:"p-5 sm:p-6",children:[e.jsx("p",{className:"text-[12px] uppercase tracking-[0.22em] text-primary font-semibold",children:a.time[t]}),e.jsx("h3",{className:"mt-2 font-serif text-xl text-foreground leading-tight",children:a.title[t]}),e.jsx("p",{className:"mt-3 whitespace-pre-line text-sm leading-relaxed text-muted-foreground",children:a.items[t]}),e.jsxs("div",{className:"mt-4 flex flex-wrap gap-x-4 gap-y-1 text-[13px] font-medium text-primary",children:[e.jsxs("span",{children:[a.kcal," ",i.kcal]}),e.jsx("span",{className:"text-muted-foreground",children:"·"}),e.jsxs("span",{children:[i.fat," ",a.fat," g"]}),e.jsx("span",{className:"text-muted-foreground",children:"·"}),e.jsxs("span",{children:[i.protein," ",a.protein," g"]}),e.jsx("span",{className:"text-muted-foreground",children:"·"}),e.jsxs("span",{children:[i.carbs," ",a.carbs," g"]})]})]})]},a.key))}),e.jsxs("div",{className:"mt-10 flex flex-col gap-6 rounded-2xl border border-primary/30 bg-gradient-to-br from-primary/10 via-primary/5 to-canvas/40 p-6 sm:p-8 sm:flex-row sm:items-center sm:justify-between",children:[e.jsxs("div",{children:[e.jsx("p",{className:"text-[12px] uppercase tracking-[0.22em] text-primary font-semibold",children:i.totals}),e.jsxs("p",{className:"mt-2 font-serif text-2xl text-foreground",children:[l.kcal," ",i.kcal,e.jsx("span",{className:"mx-2 text-muted-foreground",children:"·"}),i.fat," ",l.fat," g",e.jsx("span",{className:"mx-2 text-muted-foreground",children:"·"}),i.protein," ",l.protein," g",e.jsx("span",{className:"mx-2 text-muted-foreground",children:"·"}),i.carbs," ",l.carbs," g"]}),e.jsx("p",{className:"mt-3 max-w-2xl text-sm text-muted-foreground",children:i.note})]}),e.jsxs("button",{type:"button",onClick:c,disabled:s,className:"inline-flex items-center gap-2 rounded-full bg-primary px-5 py-3 text-sm font-medium text-primary-foreground shadow-sm transition hover:bg-primary/90 disabled:opacity-70",children:[s?e.jsx(I,{className:"h-4 w-4 animate-spin"}):e.jsx(ee,{className:"h-4 w-4"}),s?i.downloading:i.download]})]})]})}const xe="/assets/keto-hero-DNww0xnK.jpg",w={et:"Näita kõiki",ru:"Показать все",en:"Show all"},j={et:"Näita vähem",ru:"Показать меньше",en:"Show less"},ke=[{year:"2024",journal:"Psychiatry Research",pmid:"38547601",title:"Ketogenic Diet Intervention on Metabol
14ic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial",tag:{et:"Psühhiaatria",ru:"Психиатрия",en:"Psychiatry"},summary:{et:"Stanfordi pilootuuring: 4-kuuline ketogeenne dieet parandas oluliselt metaboolseid markereid ja psühhiaatrilisi sümptomeid bipolaarse häire ja skisofreeniaga patsientidel.",ru:"Пилотное исследование Стэнфорда: 4-месячная кетогенная диета значительно улучшила метаболические маркеры и психиатрические симптомы у пациентов с биполярным расстройством и шизофренией.",en:"Stanford pilot trial: a 4-month ketogenic diet significantly improved metabolic markers and psychiatric symptoms in patients with bipolar disorder and schizophrenia."}},{year:"2024",journal:"J Nutr Health Aging",pmid:"38943982",title:"Effects of ketogenic diet on cognitive function of patients with Alzheimer’s disease: a systematic review and meta-analysis",tag:{et:"Alzheimer",ru:"Альцгеймер",en:"Alzheimer’s"},summary:{et:"Meta-analüüs: ketogeenne dieet parandas kognitiivseid skoore (ADAS-Cog, MMSE) varase ja mõõduka Alzheimeri tõvega patsientidel võrreldes standardse toitumisega.",ru:"Мета-анализ: кетогенная диета улучшила когнитивные показатели (ADAS-Cog, MMSE) у пациентов с ранней и умеренной болезнью Альцгеймера по сравнению со стандартным питанием.",en:"Meta-analysis: ketogenic diet improved cognitive scores (ADAS-Cog, MMSE) in patients with early and moderate Alzheimer’s disease compared with standard nutrition."}},{year:"2024",journal:"Nutrients",pmid:"38892480",title:"The Potential Effects of the Ketogenic Diet in Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder",tag:{et:"Vaimne tervis",ru:"Психическое здоровье",en:"Mental health"},summary:{et:"Ülevaade β-hüdroksübutüraadi rollist neuroinflammatsiooni vähendamisel ja neurotransmitterite tasakaalu taastamisel meeleolu- ja ärevushäirete korral.",ru:"Обзор роли β-гидроксибутирата в снижении нейровоспаления и восстановлении баланса нейромедиаторов при расстройствах настроения и тревожных расстройствах.",en:"Review of the role of β-hydroxybutyrate in reducing neuroinflammation and restoring neurotransmitter balance in mood and anxiety disorders."}},{year:"2024",journal:"Nutr Metab Cardiovasc Dis",pmid:"38310076",title:"Effect of ketogenic diet on blood pressure: A GRADE-Assessed systematic review and meta-analysis",tag:{et:"Süda & veresooned",ru:"Сердце и сосуды",en:"Cardiovascular"},summary:{et:"GRADE-meta-analüüs: ketogeenne dieet alandab süstoolset ja diastoolset vererõhku ülekaaluga ja metaboolse sündroomiga patsientidel.",ru:"GRADE мета-анализ: кетогенная диета снижает систолическое и диастолическое давление у пациентов с избыточным весом и метаболическим синдромом.",en:"GRADE meta-analysis: ketogenic diet lowers systolic and diastolic blood pressure in patients with excess weight and metabolic syndrome."}},{year:"2023",journal:"Curr Nutr Rep",pmid:"36695999",title:"Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)",tag:{et:"PCOS",ru:"СПКЯ",en:"PCOS"},summary:{et:"Kliiniline ülevaade: ketogeenne dieet parandab insuliinitundlikkust, androgeenide profiili, kehakaalu ja menstruatsioonitsükli regulaarsust PCOS-iga naistel.",ru:"Клинический обзор: кетогенная диета улучшает чувствительность к инсулину, профиль андрогенов, вес и регулярность менструального цикла у женщин с СПКЯ.",en:"Clinical review: ketogenic diet improves insulin sensitivity, androgen profile, body weight and menstrual cycle regularity in women with PCOS."}},{year:"2023",journal:"Diabetes Metab Syndr",pmid:"38006799",title:"The effects of the ketogenic diet for the management of type 2 diabetes mellitus: A systematic review and meta-analysis of recent studies",tag:{et:"2. tüüpi diabeet",ru:"Диабет 2 типа",en:"Type 2 diabetes"}
14,summary:{et:"Värske meta-analüüs randomiseeritud uuringutest: ketogeenne dieet alandab HbA1c, tühjakõhu glükoosi ja kehakaalu ning vähendab diabeediravimite vajadust.",ru:"Свежий мета-анализ рандомизированных исследований: кетогенная диета снижает HbA1c, глюкозу натощак и вес, а также уменьшает потребность в препаратах от диабета.",en:"Recent meta-analysis of RCTs: ketogenic diet lowers HbA1c, fasting glucose and body weight, and reduces the need for diabetes medications."}},{year:"2022",journal:"Nutrients",pmid:"36501033",title:"The Role of Ketogenic Diet in the Treatment of Neurological Diseases",tag:{et:"Neuroloogia",ru:"Неврология",en:"Neurology"},summary:{et:"Ülevaade ketogeense dieedi neuroprotektiivsest toimest: epilepsia, Alzheimeri ja Parkinsoni tõbi, migreen, traumaatilised ajukahjustused.",ru:"Обзор нейропротективного действия кетогенной диеты: эпилепсия, болезни Альцгеймера и Паркинсона, мигрень, черепно-мозговые травмы.",en:"Review of the neuroprotective effects of the ketogenic diet: epilepsy, Alzheimer’s and Parkinson’s disease, migraine, traumatic brain injuries."}},{year:"2022",journal:"Int J Environ Res Public Health",pmid:"36293616",title:"Mediterranean Diet versus Very Low-Calorie Ketogenic Diet: Effects on Body Composition",tag:{et:"Kehakaal",ru:"Вес тела",en:"Body weight"},summary:{et:"Võrdlev kohortuuring: VLCKD saavutas 5% kehakaalu languse kiiremini ja säilitas lihasmassi paremini kui Vahemere dieet ülekaaluga patsientidel.",ru:"Сравнительное когортное исследование: VLCKD быстрее обеспечивала снижение веса на 5% и лучше сохраняла мышечную массу, чем средиземноморская диета у пациентов с избыточным весом.",en:"Comparative cohort study: VLCKD achieved 5% weight loss faster and preserved muscle mass better than the Mediterranean diet in overweight patients."}},{year:"2021",journal:"Nutrients",pmid:"33652834",title:"Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes",tag:{et:"2. tüüpi diabeet",ru:"Диабет 2 типа",en:"Type 2 diabetes"},summary:{et:"Pikaajaline jälgimine: VLCKD tagab püsiva HbA1c languse, kehakaalu languse ja diabeediravimite vähendamise rasvumise ja T2DM-iga patsientidel.",ru:"Долгосрочное наблюдение: VLCKD обеспечивает устойчивое снижение HbA1c, веса и потребности в препаратах от диабета у пациентов с ожирением и СД2.",en:"Long-term follow-up: VLCKD delivers sustained reductions in HbA1c, body weight and diabetes-medication needs in patients with obesity and T2DM."}},{year:"2020",journal:"Front Endocrinol",pmid:"33042004",title:"Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) in Reducing Visceral and Liver Fat in Patients With Obesity",tag:{et:"Rasvmaks (NAFLD)",ru:"Жировой гепатоз (НАЖБП)",en:"Fatty liver (NAFLD)"},summary:{et:"Randomiseeritud uuring: VLCKD vähendas vistseraalset rasva ja maksa rasvasisaldust (MRI) oluliselt enam kui standardne madala kalorsusega dieet.",ru:"Рандомизированное исследование: VLCKD снизила висцеральный жир и содержание жира в печени (МРТ) значительно сильнее, чем стандартная низкокалорийная диета.",en:"Randomised trial: VLCKD reduced visceral fat and liver fat (MRI) significantly more than a standard low-calorie diet."}},{year:"2023",journal:"Seizure",pmid:"37769548",title:"Modified Atkins diet for drug-resistant epilepsy: A systematic review and meta-analysis of randomized controlled trials",tag:{et:"Epilepsia",ru:"Эпилепсия",en:"Epilepsy"},summary:{et:"Meta-analüüs RCT-dest: modifitseeritud Atkinsi dieet (ketogeense lähenemise variant) vähendab oluliselt krampide sagedust ravimresistentse epilepsiaga patsientidel.",ru:"Мета-анализ РКИ: модифицированная диета Аткинса (вариант кетогенного подхода) значительно снижает частоту приступов у пациентов с лекарственно-устойчивой эпилепсией.",en:"Meta-analysis of RCTs: the modified Atkins diet (a ketogenic variant) significantly reduces seizure frequency in patients with drug-resistant epilepsy."}},{year:"2023",journal:"Nutrients",pmid:"37892410",title:"The Effect of Three Different Ketogenic Diet Protocols on Migraine and Fatigue in Chronic and High-Frequency Migraine",tag:{et:"Migreen",ru:"Мигрень",en:"Migraine"},summary:{et:"Kliiniline uuring: kolm ketogeense dieedi protokolli vähendasid migreenipäevade arvu ja väsimust kroonilise ning sagedase migreeniga patsientidel.",ru:"Клиническое исследование: три протокола кетогенной диеты снизили число дней с мигренью и утомляемость у пациентов с хронической и частой мигренью.",en:"Clinical study: three ketogenic diet protocols reduced migraine days and fatigue in patients with chronic and high-frequency migraine."}}],be=[{year:"2024",journal:"Front Nutr",pmid:"39385794",title:"Impact of low-carbohydrate diet on health status: an umbrella review",tag:{et:"Üldine tervis",ru:"Общее здоровье",en:"General health"},summary:{et:"Umbrella-ülevaade meta-analüüsidest: madala süsivesikusisaldusega toitumine parandab kehakaalu, glükoosi reguleerimist, lipiidide profiil
14i ja vererõhku.",ru:"Обзор зонтичного типа: низкоуглеводное питание улучшает вес, регуляцию глюкозы, липидный профиль и артериальное давление.",en:"Umbrella review of meta-analyses: low-carbohydrate nutrition improves body weight, glucose regulation, lipid profile and blood pressure."}},{year:"2024",journal:"Front Nutr",pmid:"39834467",title:"The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of RCTs",tag:{et:"2. tüüpi diabeet",ru:"Диабет 2 типа",en:"Type 2 diabetes"},summary:{et:"Meta-analüüs randomiseeritud kliinilistest uuringutest: low-carb dieet alandab HbA1c, tühjakõhu glükoosi ja LDL-i ülekaaluga T2DM-iga patsientidel.",ru:"Мета-анализ РКИ: низкоуглеводная диета снижает HbA1c, глюкозу натощак и LDL у пациентов с избыточным весом и СД2.",en:"Meta-analysis of RCTs: a low-carb diet lowers HbA1c, fasting glucose and LDL in overweight patients with T2DM."}},{year:"2024",journal:"Food Funct",pmid:"39555961",title:"A network meta-analysis of the comparative efficacy of different dietary approaches on glycemic control and weight loss in T2DM",tag:{et:"Diabeedi remissioon",ru:"Ремиссия диабета",en:"Diabetes remission"},summary:{et:"Võrgustiku meta-analüüs: madala süsivesikusisaldusega ja ketogeenne dieet kuuluvad kõige tõhusamate toitumisstrateegiate hulka glükeemia kontrollil ja kehakaalu languses.",ru:"Сетевой мета-анализ: низкоуглеводная и кетогенная диеты входят в число наиболее эффективных стратегий питания для контроля гликемии и снижения веса.",en:"Network meta-analysis: low-carbohydrate and ketogenic diets are among the most effective dietary strategies for glycemic control and weight loss."}}],fe=t=>`https://europepmc.org/article/MED/${t}`,ve={et:{eyebrow:"Konsultatsiooni teema",h1:"Keto ja raviketoos",lead:"Ketogeenne ja madala süsivesikusisaldusega toitumine on toitumisviisid, mille sobivust saab arutada konsultatsioonil, arvestades terviseseisundit, ravimeid, anamneesi ja eesmärke. See leht annab lühikese neutraalse ülevaate teemast.",ctaBook:"Vali konsultatsioon",topicsEyebrow:"Teemad konsultatsioonil",topicsH:"Millal saab madala süsivesikusisaldusega toitumist arutada",topicsLead:"Allpool toodud teemasid on võimalik konsultatsioonil arutada. Loetelu on neutraalse iseloomuga ega ole ravisoovitus, näidustuste loend ega lubadus konkreetse tulemuse osas. Iga olukorda hinnatakse individuaalselt.",warn:"Kui kasutate ravimeid (eriti diabeedi- või vererõhuravimeid), arutage toitumismuudatusi alati eelnevalt oma raviarstiga.",faqEyebrow:"KKK",faqH:"Korduma kippuvad küsimused",topics:["2. tüüpi diabeet või eeldiabeet","Insuliiniresistentsus (kõrge tühjakõhu insuliin või HOMA-IR)","Metaboolne sündroom (kõrged triglütseriidid, madal HDL, ülekaal, kõrge vererõhk, kõrge kusihape)","Ülekaal","Vistseraalne rasvumine ja kõhurasv","PCOS (polütsüstiliste munasarjade sündroom)","Mittealkohoolne rasvmaksa haigus (NAFLD)","Epilepsia (klassikaline kliiniline näidustus, kus toitumisviisi kasutatakse arsti järelevalve all)"],faqs:[{q:"Mis on ketogeenne toitumine?",a:"Ketogeenne toitumine on toitumisviis, kus süsivesikute kogust on oluliselt piiratud ja organism kasutab energiana suuremas osas rasvhappeid ja ketokehasid. Sobivust hinnatakse alati individuaalselt, arvestades terviseseisundit ja ravimeid."},{q:"Kas see toitumisviis sobib igaühele?",a:"Ei. Ketogeenne või madala süsivesikusisaldusega toitumine ei sobi kõigile ja võib olla vastunäidustatud teatud terviseseisundite ning ravimite korral. Sobivust saab arutada konsultatsioonil."},{q:"Kas ma võin alustada iseseisvalt?",a:"Kui kasutate ravimeid (eriti diabeedi- või vererõhuravimeid), ei soovita mina suuri toitumismuudatusi teha ilma raviarsti hinnanguta. Individuaalse sobivuse hindamiseks broneerige konsultatsioon."},{q:"Kuidas konsultatsioon toimub?",a:"Konsultatsioonil vaatame koos läbi teie terviseandmed, eesmärgid, anamneesi ja võimalikud edasised sammud. Konsultatsioon ei taga ühtegi konkreetset tulemust."}]},ru:{eyebrow:"Тема консультации",h1:"Кето и лечебный кетоз",lead:"Кетогенное и низкоуглеводное питание – это варианты питания, чью применимость можно обсудить на консультации с учётом состояния здоровья, принимаемых лекарств, анамнеза и целей. На этой странице – краткий нейтральный обзор темы.",ctaBook:"Выбрать консультацию",topicsEyebrow:"Темы на консультации",topicsH:"Когда можно обсудить низкоуглеводное питание",topicsLead:"Перечисленные ниже темы можно обсудить на консультации. Список носит нейтральный характер и не явÐ
14»ÑÐµÑ‚ся назначением лечения, перечнем показаний или обещанием конкретного результата. Каждая ситуация оценивается индивидуально.",warn:"Если вы принимаете лекарства (особенно от диабета или давления), всегда обсуждайте изменения питания заранее со своим лечащим врачом.",faqEyebrow:"FAQ",faqH:"Часто задаваемые вопросы",topics:["Сахарный диабет 2 типа или преддиабет","Инсулинорезистентность (высокий инсулин натощак или HOMA-IR)","Метаболический синдром (высокие триглицериды, низкий HDL, избыточный вес, высокое давление, высокая мочевая кислота)","Избыточный вес","Висцеральное ожирение и абдоминальный жир","СПКЯ (синдром поликистозных яичников)","Неалкогольная жировая болезнь печени (НАЖБП)","Эпилепсия (классическое клиническое показание, где такое питание применяется под наблюдением врача)"],faqs:[{q:"Что такое кетогенное питание?",a:"Кетогенное питание – это вариант питания, при котором количество углеводов значительно ограничено, а организм использует в качестве энергии преимущественно жирные кислоты и кетоновые тела. Применимость всегда оценивается индивидуально, с учётом состояния здоровья и принимаемых лекарств."},{q:"Подходит ли такой стиль питания всем?",a:"Нет. Кетогенное или низкоуглеводное питание подходит не всем и может быть противопоказано при определённых состояниях и приёме определённых лекарств. Применимость можно обсудить на консультации."},{q:"Можно ли начать самостоятельно?",a:"Если вы принимаете лекарства (особенно от диабета или давления), я не рекомендую вносить большие изменения в питание без оценки лечащего врача. Для индивидуальной оценки запишитесь на консультацию."},{q:"Как проходит консультация?",a:"На консультации мы вместе разбираем ваши данные здоровья, цели, анамнез и возможные дальнейшие шаги. Консультация не гарантирует какого-либо конкретного результата."}]},en:{eyebrow:"Consultation topic",h1:"Keto & therapeutic ketosis",lead:"Ketogenic and low-carbohydrate nutrition are dietary approaches whose suitability can be discussed at a consultation, taking into account your health, medications, history and goals. This page offers a brief neutral overview.",ctaBook:"Choose a consultation",topicsEyebrow:"Consultation topics",topicsH:"When low-carbohydrate nutrition can be discussed",topicsLead:"The topics listed below can be discussed at a consultation. The list is neutral and is not a treatment recommendation, list of indications or promise of any specific outcome. Every situation is assessed individually.",warn:"If you take medications (especially for diabetes or blood pressure), always discuss dietary changes with your treating physician in advance.",faqEyebrow:"FAQ",faqH:"Frequently asked questions",topics:["Type 2 diabetes or prediabetes","Insulin resistance (high fasting insulin or HOMA-IR)","Metabol
14ic syndrome (high triglycerides, low HDL, excess weight, high blood pressure, high uric acid)","Excess weight","Visceral obesity and abdominal fat","PCOS (polycystic ovary syndrome)","Non-alcoholic fatty liver disease (NAFLD)","Epilepsy (a classic clinical indication where this dietary approach is used under medical supervision)"],faqs:[{q:"What is ketogenic nutrition?",a:"Ketogenic nutrition is a dietary approach where carbohydrate intake is significantly restricted and the body uses mainly fatty acids and ketone bodies for energy. Suitability is always assessed individually, taking into account health status and medications."},{q:"Does this dietary approach suit everyone?",a:"No. Ketogenic or low-carbohydrate nutrition does not suit everyone and may be contraindicated for certain health conditions and medications. Suitability can be discussed at a consultation."},{q:"Can I start on my own?",a:"If you take medications (especially for diabetes or blood pressure), I do not recommend making big dietary changes without your treating physician’s assessment. Book a consultation for an individual assessment."},{q:"How does the consultation work?",a:"At the consultation we review your health data, goals, history and possible next steps together. A consultation does not guarantee any specific outcome."}]}},r={et:{cmpEyebrow:"Low-carb vs Keto",cmpH:"Mis vahe on madala süsivesikusisaldusega ja ketogeensel toitumisel?",cmpLead:"Mõlemad lähenemised piiravad süsivesikuid, kuid erinevad süsivesikute kogusest, eesmärgist, metaboolsest seisundist ja kliinilisest rakendusest. Allpool on neutraalne ülevaade – sobivust hinnatakse alati individuaalselt.",lcTitle:"Madala süsivesikusisaldusega (Low-carb)",lcDesc:"Süsivesikute piiramine tavaliselt vahemikus 50–130 g päevas. Eesmärk on stabiliseerida veresuhkur, insuliini ja vähendada söögiisu, säilitades samal ajal toidu paindlikkuse. Ketokehade tase tõuseb vaid mõõdukalt või jääb madalaks.",lcBullets:["Süsivesikud: 50–130 g päevas (~10–25% energiast)","Lubatud puuviljad, kaunviljad, juurviljad mõõdukalt","Ketoos pole eesmärk – paindlik igapäevane toitumine","Sobib alustamiseks, kerge insuliiniresistentsuse ja kehakaalu korral","Lihtsam sotsiaalselt ja pikaajaliselt järgida"],ketoTitle:"Ketogeenne (Keto)",ketoDesc:"Süsivesikute oluline piiramine, tavaliselt alla 20–50 g päevas, koos kõrge rasvasisalduse ja mõõduka valgusisaldusega. Eesmärk on viia organism toitumusliku ketoosi seisundisse, kus ketokehad (β-hüdroksübutüraat) muutuvad peamiseks ajukütuseks.",ketoBullets:["Süsivesikud: <20–50 g päevas (~5–10% energiast)","Rasv 70–80%, valk 15–25% energiast","Vere ketokehad 0,5–3,0 mmol/L (mõõdetav)","Kliiniline kasutus: epilepsia, T2DM, NAFLD, PCOS, neuroloogia","Vajab täpsemat planeerimist ja sageli arsti järelevalvet"],tParam:"Parameeter",table:[["Süsivesikud (g/päevas)","50–130","<20–50"],["Rasva osakaal","30–50%","70–80%"],["Vere ketoonid","Madalad (<0,3 mmol/L)","0,5–3,0 mmol/L"],["Peamine kütus","Glükoos + rasvhapped","Rasvhapped + ketokehad"],["Eesmärk","Veresuhkru stabiliseerimine","Toitumuslik ketoos"],["Paindlikkus","Kõrge","Madalam, struktureeritum"],["Sotsiaalne kohanemine","Lihtne","Nõuab planeerimist"],["Valdkonnad, kus on uuritud","2. tüüpi diabeet, ülekaal, metaboolne sündroom","Epilepsia, 2. tüüpi diabeet, rasvmaks, neuroloogia"],["Järelevalve","Soovitatav","Eriti soovitatav ravimite korral"]],ketoResEyebrow:"Teadusartiklid · 2019–2024",ketoResH:"12 retsenseeritud uuringut ketogeense toitumise kohta",ketoResLead:"Värsked retsenseeritud publikatsioonid ketogeense dieedi mõjust eri elu- ja tervisevaldkondadele. Kliki kaardil – link avab uuringu Europe PMC andmebaasis.",lcResEyebrow:"Teadusartiklid · 2024",lcResH:"Värsked uuringud madala süsivesikusisaldusega toitumise kohta",lcResLead:"Hiljutised retsenseeritud publikatsioonid low-carb lähenemise mõjust kehakaalule, diabeedile ja üldisele tervisele.",readStudy:"Loe uuringut Europe PMC-s"},ru:{cmpEyebrow:"Low-carb vs Кето",cmpH:"В чём разница между низкоуглеводным и кетогенным питанием?",cmpLead:"Оба подхода ограничивают углеводы, но различаются по количеству углеводов, цели, метаболическому состоянию и клиническому применению. Ниже – Ð
14½ÐµÐ¹Ñ‚ральный обзор. Применимость всегда оценивается индивидуально.",lcTitle:"Низкоуглеводное (Low-carb)",lcDesc:"Ограничение углеводов обычно в диапазоне 50–130 г в день. Цель – стабилизировать сахар крови и инсулин, снизить аппетит, сохраняя гибкость питания. Уровень кетоновых тел повышается умеренно или остаётся низким.",lcBullets:["Углеводы: 50–130 г/день (~10–25% энергии)","Разрешены фрукты, бобовые, корнеплоды в умеренных количествах","Кетоз не является целью – гибкое повседневное питание","Подходит для старта, при лёгкой инсулинорезистентности и снижении веса","Проще соблюдать социально и долгосрочно"],ketoTitle:"Кетогенное (Keto)",ketoDesc:"Существенное ограничение углеводов, обычно менее 20–50 г в день, в сочетании с высоким содержанием жиров и умеренным белком. Цель – ввести организм в состояние пищевого кетоза, при котором кетоновые тела (β-гидроксибутират) становятся основным топливом для мозга.",ketoBullets:["Углеводы: <20–50 г/день (~5–10% энергии)","Жиры 70–80%, белок 15–25% энергии","Кетоны в крови 0,5–3,0 ммоль/л (измеряемо)","Клиническое применение: эпилепсия, СД2, НАЖБП, СПКЯ, неврология","Требует более точного планирования и часто контроля врача"],tParam:"Параметр",table:[["Углеводы (г/день)","50–130","<20–50"],["Доля жиров","30–50%","70–80%"],["Кетоны в крови","Низкие (<0,3 ммоль/л)","0,5–3,0 ммоль/л"],["Основное топливо","Глюкоза + жирные кислоты","Жирные кислоты + кетоны"],["Цель","Стабилизация сахара крови","Пищевой кетоз"],["Гибкость","Высокая","Ниже, более структурировано"],["Социальная адаптация","Простая","Требует планирования"],["Области, где это изучалось","СД2, лишний вес, метаболический синдром","Эпилепсия, СД2, жировая болезнь печени, неврология"],["Наблюдение","Рекомендовано","Особо рекомендовано при приёме лекарств"]],ketoResEyebrow:"Научные статьи · 2019–2024",ketoResH:"12 рецензируемых исследований по кетогенному питанию",ketoResLead:"Свежие рецензируемые публикации о влиянии кето на разные сферы здоровья и жизни. Кликните по карточке – ссылка откроет исследование в Europe PMC.",lcResEyebrow:"Научные статьи · 2024",lcResH:"Свежие исследования по низкоуглеводному питанию",lcResLead:"Недавние рецензируемые публикации о влиянии low-carb на вес, диабет и общее состояние здоровья.",readStudy:"Читать в Europe PMC"},en:{cmpEyebrow:"Low-carb vs Keto",cmpH:"What is the difference between low-carb and ketogenic nutrition?",cmpLead:"Both approaches restrict carbohydrates, but they differ in carb amount, goal, metabolic state and clinical use. The overview below is neutral – suitability is always assessed individually.",lcTitle:"Low-carbohydrate (Low-carb)",lcDesc:"Carbohydrate restriction usually in the 50–130 g/day range. The aim is to stabilize blood glucose and insulin and reduce appetite while keeping dietary flexibility. Blood ketones rise only modestly or stay low.",lcBullets:["Carbs: 50–130 g/day (~10–25% of energy)","Fruits, legumes and root vegetables allowed in moderation","Ketosis is not the goal – flexible everyday eating","Suitable to start with, for mild insulin resistance and weight goals","Easier to follow socially and long-term"],ketoTitle:"Ketogenic (Keto)",ketoDesc:"Significant carbohydrate restriction, typically below 20–50 g/day, combined with high fat and moderate protein. The aim is to induce nutritional ketosis, where ketone bodies (β-hydroxybutyrate) become the brain’s primary fuel.",ketoBullets:["Carbs: <20–50 g/day (~5–10% of energy)","Fat 70–80%, protein 15–25% of energy","Blood ketones 0.5–3.0 mmol/L (measurable)","Clinical use: epilepsy, T2DM, NAFLD, PCOS, neurology","Requires more planning and often medical supervision"],tParam:"Parameter",table:[["Carbohydrates (g/day)","50–130","<20–50"],["Fat share","30–50%","70–80%"],["Blood ketones","Low (<0.3 mmol/L)","0.5–3.0 mmol/L"],["Primary fuel","Glucose + fatty acids","Fatty acids + ketones"],["Goal","Stabilise blood glucose","Nutritional ketosis"],["Flexibility","High","Lower, more structured"],["Social adaptation","Easy","Requires planning"],["Areas where it has been studied","T2DM, excess weight, metabolic 
14syndrome","Epilepsy, T2DM, fatty liver disease, neurology"],["Supervision","Recommended","Especially recommended with medications"]],ketoResEyebrow:"Research · 2019–2024",ketoResH:"12 peer-reviewed studies on ketogenic nutrition",ketoResLead:"Recent peer-reviewed publications on the effects of the ketogenic diet across different areas of health and life. Click a card to open the study in Europe PMC.",lcResEyebrow:"Research · 2024",lcResH:"Recent studies on low-carbohydrate nutrition",lcResLead:"Recent peer-reviewed publications on the effects of low-carb on body weight, diabetes and overall health.",readStudy:"Read in Europe PMC"}};function C({a:t,cta:i,locale:s}){return e.jsxs("a",{href:fe(t.pmid),target:"_blank",rel:"noopener noreferrer",className:"group relative flex h-full flex-col rounded-2xl border border-border bg-card p-6 shadow-[var(--shadow-soft)] transition-all duration-300 hover:-translate-y-0.5 hover:border-primary/40 hover:shadow-[var(--shadow-float)]",children:[e.jsxs("div",{className:"flex items-start justify-between gap-3",children:[e.jsx("div",{className:"grid h-10 w-10 place-content-center rounded-xl bg-primary/10 ring-1 ring-primary/20",children:e.jsx(M,{className:"h-4 w-4 text-primary"})}),e.jsxs("span",{className:"text-[10.5px] font-semibold uppercase tracking-[0.14em] text-muted-foreground text-right",children:[t.year," · ",t.journal]})]}),e.jsx("span",{className:"mt-3 inline-flex w-fit items-center rounded-full bg-canvas/70 px-2.5 py-0.5 text-[10.5px] font-medium tracking-wide text-foreground/70 ring-1 ring-border",children:t.tag[s]}),e.jsx("h4",{className:"mt-3 font-serif text-[16.5px] leading-snug text-foreground",children:t.title}),e.jsx("p",{className:"mt-2 text-[13.5px] leading-relaxed text-foreground/75",children:t.summary[s]}),e.jsxs("span",{className:"mt-4 inline-flex items-center gap-1.5 text-[13px] font-medium text-primary transition-all group-hover:gap-2.5",children:[i," ",e.jsx(re,{className:"h-3.5 w-3.5"})]})]})}function Ee(){const{locale:t}=E(),i=ve[t];return e.jsxs("div",{className:"min-h-dvh flex flex-col bg-background",children:[e.jsx($,{serviceId:"keto"}),e.jsx(_,{}),e.jsx(O,{}),e.jsxs("main",{className:"flex-1 bg-canvas/40",children:[e.jsx(te,{}),e.jsx("section",{className:"border-b border-border bg-background",children:e.jsx("div",{className:"mx-auto max-w-6xl px-4 sm:px-6 lg:px-8 py-16 lg:py-24",children:e.jsxs("div",{className:"grid gap-10 lg:gap-14 items-center lg:grid-cols-[1.1fr_1fr]",children:[e.jsxs("div",{children:[e.jsxs("div",{className:"inline-flex items-center gap-2 rounded-full border border-primary/30 bg-primary/5 px-3 py-1 text-[13px] uppercase tracking-[0.18em] text-primary",children:[e.jsx(L,{className:"h-3 w-3"}),i.eyebrow]}),e.jsx("h1",{className:"mt-6 font-serif text-3xl md:text-4xl lg:text-[2.75rem] font-medium tracking-tight leading-[1.1] text-foreground",children:i.h1}),e.jsx("p",{className:"mt-6 max-w-3xl text-base sm:text-lg leading-relaxed text-foreground/80",children:i.lead}),e.jsx("div",{className:"mt-8 flex flex-wrap gap-3",children:e.jsxs(k,{to:`/vali-konsultatsioon?for=keto${t==="et"?"":`&lang=${t}`}`,className:"inline-flex items-center gap-2 rounded-full bg-primary px-6 py-3 text-sm font-medium text-primary-foreground hover:opacity-90 transition shadow-[var(--shadow-soft)]",children:[e.jsx(L,{className:"h-4 w-4"})," ",i.ctaBook]})})]}),e.jsx("div",{className:"order-first lg:order-none",children:e.jsx("img",{src:xe,alt:"Ketogeenne toit – värske lõhe, avokaado, rohelised ja tervislikud rasvad Põhjamaa köögis",width:1600,height:1e3,className:"w-full h-auto rounded-3xl shadow-[var(--shadow-float)] object-cover aspect-[16/10]",loading:"eager",fetchPriority:"high",decoding:"async"})})]})})}),e.jsx("section",{className:"mx-auto max-w-5xl px-4 pt-10 sm:px-6 lg:px-8",children:e.jsx(ie,{})}),e.jsxs("section",{className:"mx-auto max-w-5xl px-4 sm:px-6 lg:px-8 py-16 lg:py-20",children:[e.jsxs("div",{className:"max-w-3xl",children:[e.jsx("p",{className:"text-[13px] uppercase tracking-[0.22em] text-primary",children:i.topicsEyebrow}),e.jsx("h2",{className:"mt-3 font-serif text-3xl sm:text-4xl text-foreground leading-tight",children:i.topicsH}),e.jsx("p",{className:"mt-4 text-sm sm:text-base leading-relaxed text-muted-foreground",children:i.topicsLead})]}),e.jsx(y,{className:"mt-10",initial:4,gridClassName:"grid gap-3 sm:grid-cols-2",moreLabel:w[t],lessLabel:j[t],context:"keto_topics",children:i.topics.map(s=>e.jsxs("div",{className:"flex items-start gap-3 rounded-2xl border border-border bg-card px-5 py-4 shadow-[var(--shadow-soft)]",children:[e.jsx("span",{className:"mt-1.5 h-1.5 w-1.5 shrink-0 rounded-full bg-primary"}),e.jsx("span",{className:"text-sm sm:text-[15px] leading-relaxed text-foreground
14/85",children:s})]},s))}),e.jsx("div",{className:"mt-10 rounded-2xl border border-amber-200/60 bg-amber-50/40 px-5 py-4 text-[13px] leading-relaxed text-foreground/80",children:i.warn})]}),e.jsx("section",{className:"border-y border-border bg-background",children:e.jsxs("div",{className:"mx-auto max-w-6xl px-4 sm:px-6 lg:px-8 py-16 lg:py-20",children:[e.jsxs("div",{className:"max-w-3xl",children:[e.jsxs("p",{className:"inline-flex items-center gap-2 text-[13px] uppercase tracking-[0.22em] text-primary",children:[e.jsx(se,{className:"h-3.5 w-3.5"})," ",r[t].cmpEyebrow]}),e.jsx("h2",{className:"mt-3 font-serif text-3xl sm:text-4xl text-foreground leading-tight",children:r[t].cmpH}),e.jsx("p",{className:"mt-4 text-sm sm:text-base leading-relaxed text-muted-foreground",children:r[t].cmpLead})]}),e.jsxs("div",{className:"mt-10 grid gap-5 lg:grid-cols-2",children:[e.jsxs("div",{className:"rounded-2xl border border-border bg-card p-6 sm:p-8 shadow-[var(--shadow-soft)]",children:[e.jsx("div",{className:"inline-flex items-center gap-2 rounded-full bg-primary/10 px-3 py-1 text-[13px] font-semibold uppercase tracking-[0.16em] text-primary",children:"Low-carb"}),e.jsx("h3",{className:"mt-3 font-serif text-2xl text-foreground",children:r[t].lcTitle}),e.jsx("p",{className:"mt-3 text-[14.5px] leading-relaxed text-foreground/80",children:r[t].lcDesc}),e.jsx("ul",{className:"mt-4 space-y-2 text-[14px] text-foreground/85",children:r[t].lcBullets.map(s=>e.jsxs("li",{className:"flex gap-2",children:[e.jsx("span",{className:"mt-2 h-1.5 w-1.5 shrink-0 rounded-full bg-primary"}),s]},s))})]}),e.jsxs("div",{className:"rounded-2xl border border-primary/40 bg-primary/5 p-6 sm:p-8 shadow-[var(--shadow-soft)]",children:[e.jsx("div",{className:"inline-flex items-center gap-2 rounded-full bg-primary px-3 py-1 text-[13px] font-semibold uppercase tracking-[0.16em] text-primary-foreground",children:"Keto"}),e.jsx("h3",{className:"mt-3 font-serif text-2xl text-foreground",children:r[t].ketoTitle}),e.jsx("p",{className:"mt-3 text-[14.5px] leading-relaxed text-foreground/80",children:r[t].ketoDesc}),e.jsx("ul",{className:"mt-4 space-y-2 text-[14px] text-foreground/85",children:r[t].ketoBullets.map(s=>e.jsxs("li",{className:"flex gap-2",children:[e.jsx("span",{className:"mt-2 h-1.5 w-1.5 shrink-0 rounded-full bg-primary"}),s]},s))})]})]}),e.jsx(ae,{className:"mt-8",headers:[r[t].tParam,"Low-carb","Keto"],rows:r[t].table.map(s=>[s[0],s[1],s[2]])})]})}),e.jsx("section",{className:"mx-auto max-w-7xl px-4 sm:px-6 lg:px-8 py-16 lg:py-20",children:e.jsxs("details",{className:"group rounded-2xl border border-border bg-card shadow-[var(--shadow-soft)]",children:[e.jsxs("summary",{className:"flex cursor-pointer items-center justify-between gap-4 px-6 py-5 sm:px-8 sm:py-6 list-none",children:[e.jsxs("div",{className:"flex items-start gap-3",children:[e.jsx(M,{className:"mt-1 h-5 w-5 shrink-0 text-primary"}),e.jsxs("div",{children:[e.jsx("p",{className:"text-[13px] uppercase tracking-[0.22em] text-primary",children:r[t].ketoResEyebrow}),e.jsxs("h2",{className:"mt-1 font-serif text-xl sm:text-2xl text-foreground leading-tight",children:[r[t].ketoResH," + ",r[t].lcResH]})]})]}),e.jsx(R,{className:"h-5 w-5 shrink-0 text-muted-foreground transition-transform group-open:rotate-90"})]}),e.jsxs("div",{className:"border-t border-border px-6 py-8 sm:px-8",children:[e.jsx("p",{className:"max-w-3xl text-sm sm:text-base leading-relaxed text-muted-foreground",children:r[t].ketoResLead}),e.jsx(y,{className:"mt-8",initial:3,gridClassName:"grid gap-4 md:grid-cols-2 lg:grid-cols-3",moreLabel:w[t],lessLabel:j[t],context:"keto_research",children:ke.map(s=>e.jsx(C,{a:s,cta:r[t].readStudy,locale:t},s.pmid))}),e.jsxs("div",{className:"mt-12 max-w-3xl",children:[e.jsx("p",{className:"text-[13px] uppercase tracking-[0.22em] text-primary",children:r[t].lcResEyebrow}),e.jsx("h3",{className:"mt-2 font-serif text-xl sm:text-2xl text-foreground leading-tight",children:r[t].lcResH}),e.jsx("p",{className:"mt-3 text-sm sm:text-base leading-relaxed text-muted-foreground",children:r[t].lcResLead})]}),e.jsx(y,{className:"mt-6",initial:3,gridClassName:"grid gap-4 md:grid-cols-3",moreLabel:w[t],lessLabel:j[t],context:"keto_lowcarb_research",children:be.map(s=>e.jsx(C,{a:s,cta:r[t].readStudy,locale:t},s.pmid))})]})]})}),e.jsx(he,{}),e.jsxs("section",{className:"mx-auto max-w-4xl px-4 sm:px-6 lg:px-8 py-16 lg:py-20",children:[e.jsxs("div",{className:"text-center max-w-2xl mx-auto",children:[e.jsxs("div",{className:"inline-flex items-center gap-2 text-[13px] uppercase tracking-[0.22em] text-primary",children:[e.jsx(ne,{className:"h-3.5 w-3.5"})," ",i.faqEyebrow]}),e.jsx("h2",{className:"mt-3 font-serif text-3xl sm:text-4xl text-foreground leading-tight",children:i.faqH})]}),e.jsx("div",{className:"mt-10 space-y-3",children:i.faqs.map((s,o)=>e.jsx(ye,{q:s.q,a:s.a,defaultOpen:o===0},s.q))})]}),e.jsx(G,{locale:t}),e.jsx(le,{locale:t,ids:["kons-25","kons-45"]}),e.jsx("section",{className:"border-t border-border bg-canvas/40",children:e.jsx("div",{className:"mx-auto max-w-7xl px-4 sm:px-6 lg:px-8 py-12 lg:py-16",children:e.jsx(U,{locale:t,variant:"full"})})})]}),e.jsx(W,{})]})}function ye({q:t,a:i,defaultOpen:s=!1}){const[o,l]=A.useState(s);return e.jsxs("div",{className:`rounded-2xl border bg-card transition-all ${o?"border-primary/40 shadow-[var(--shadow-soft)]":"border-border"}`,children:[e.jsxs("button",{onClick:()=>l(c=>!c),className:"flex w-full items-center justify-between gap-4 px-5 sm:px-6 py-5 text-left","aria-expanded":o,children:[e.jsx("span",{className:"font-serif text-base sm:text-lg leading-snug text-foreground",children:t}),e.jsx(J,{className:`h-5 w-5 shrink-0 text-primary transition-transform ${o?"rotate-180":""}`})]}),e.jsx("div",{className:`grid transition-all duration-300 ease-out ${o?"grid-rows-[1fr] opacity-100":"grid-rows-[0fr] opacity-0"}`,children:e.jsx("div",{className:"overflow-hidden",children:e.jsx("p",{className:"px-5 sm:px-6 pb-6 text-sm sm:text-[15px] leading-relaxed text-foreground
14/80",children:i})})})]})}export{Ee as K};

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.